Method of Treating Alzheimer's Disease with X-ray Minibeams


Alzheimer?s Disease is the most common form of dementia among the elderly and affects over five million individuals in the United States. To date, there is no definitive treatment to cure or halt the progression of Alzheimer?s Disease. Approved pharmacotherapies offer only modest and transient symptomatic benefits.


The proposed x-ray method replaces conventional x-ray exposures used in previous studies. This alternative is an efficient therapeutic outcome, one that is maintaining a tissue-sparing effect.


Treatment method is centered around maintaining a tissue-sparing effect allowing for 10X higher dose limits than conventional x-rays.



Patent Status

Provisional patent - Patent application submitted

Stage Of Development

Pre-clinical. - Provisional Patent Filed

Licensing Potential

Development partner - Commercial partner - Licensing 

Licensing Status

Available for license.

Additional Info

Additional Information: Source: Natasha Connell,, Unsplash License
Patent Information:
Case ID: R8852
For Information, Contact:
Donna Tumminello
Assistant Director
State University of New York at Stony Brook
Avraham Dilmanian
Renee Cattell
Lev Bangiyev
cell differentiation
computed tomography (CT) scanner
glial progenitor cells
radiation therapy
tissue-sparing effect
x-ray microbeams